Home
MAK Capital Fund reported a 11.3% stake in ADS shares of Autolus Therapeutics AUTL · 30,005,343 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 11.3%
- Last report
- 10.1% · filed 25/12/03
- Shares held
- 30,005,343 sh
- Class
- Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
- Holder
- MAK Capital Fund
- Event date
- 25/12/31
- Filed
- 26/02/13
11.3% stake · +1.2pp from the last report
- Stake
- 11.3%
- Last report
- 10.1%
- Since last report
- +1.2pp
Autolus Therapeutics trades, last 26 weeks
What else happened in Autolus Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30MAK Capital Fund's other 5% stake reports
- MAK Capital Fund
5% stakeComstock
5% stakeComstock
LODE
6.7% stake
5,065,656 sh
6.7% stake
Filed 09/16
- MAK Capital Fund
5% stakeStandard Biotools
5% stakeStandard Biotools
LAB
6.7% stake
26,172,626 sh
6.7% stake
Filed 05/15
- MAK Capital Fund
5% stakeAutolus Therapeutics
5% stakeAutolus Therapeutics
AUTL
12.6% stake
33,621,487 sh
12.6% stake
Filed 05/15
- MAK Capital Fund
5% stakeEvotec
5% stakeEvotec
EVO
7.1% stake
12,681,898 sh
7.1% stake
Filed 05/01
- MAK Capital Fund
5% stakeEvotec
5% stakeEvotec
EVO
7% stake
12,503,512 sh
7% stake
Filed 04/06
